Femasys is trading at $3.52 (-5.09%) today on likely profit-taking following a period of sharp volatility and recent gains.
- No company-specific filings, earnings updates, or major headlines have emerged this morning to explain the downward move.
- The stock is underperforming the broader biotech sector, with the XBI trading up 2.31%, suggesting the decline is idiosyncratic rather than sector-driven.
- The current weakness likely reflects a reversal after a volatile multi-day swing as investors lock in profits.